Residual tumor cells after insufficient radiofrequency ablation promote lung metastasis by educating CD177<sup>hi</sup>PAD4<sup>hi</sup> neutrophils.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41330923.
- Also identified by DOI 10.1038/s41467-025-66897-0 and PMC identifier 12780263.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Radiofrequency ablation (RFA) has been one of the most promising local treatments for colorectal liver metastases. However, tumor progression after RFA still severely affects patient prognosis, and its molecular mechanisms remain to be further explored. Here, we show that heat-stressed residual tumor cells following insufficient RFA (iRFA) can lead to lung metastases. Specific Cd177<sup>hi</sup>Pad4<sup>hi</sup> neutrophils are found as the main pro-tumor phenotype in iRFA conditions, and neutrophil extracellular traps are produced to accelerate lung metastasis via the MEK/ERK signaling pathway. Mechanistically, PPARγ-triglyceride (TG) synthesis in residual tumor cells activates the P38 signaling pathway and CXCL5 secretion, contributing to Cd177<sup>hi</sup>Pad4<sup>hi</sup> neutrophil infiltration. Furthermore, the specific CD36<sup>hi</sup>-EM (epithelial-mesenchymal) - circulating tumor cells (CTCs) with activated lipid metabolism characteristics are found to assist in early identification of residual tumor cells. This study not only provides specific targets for improving the efficacy of iRFA but also realizes its early identification and intervention.
Medical subject headings
- Lung Neoplasms
- Neutrophils
- Radiofrequency Ablation
- Neoplasm, Residual
- Colorectal Neoplasms
- Receptors, Cell Surface